[HTML][HTML] Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for
80%–85% of total cases and leading to millions of deaths worldwide. Drug resistance is the …
80%–85% of total cases and leading to millions of deaths worldwide. Drug resistance is the …
[HTML][HTML] Mathematical Modeling Support for Lung Cancer Therapy—A Short Review
J Smieja - International Journal of Molecular Sciences, 2023 - mdpi.com
The paper presents a review of models that can be used to describe dynamics of lung
cancer growth and its response to treatment at both cell population and intracellular …
cancer growth and its response to treatment at both cell population and intracellular …
Liquid biopsy for early detection of lung cancer
M Bibikova, J Fan - Chinese Medical Journal Pulmonary and Critical …, 2023 - mednexus.org
Lung cancer is the leading cause of cancer-related mortality worldwide. Early cancer
detection plays an important role in improving treatment success and patient prognosis. In …
detection plays an important role in improving treatment success and patient prognosis. In …
microRNAs and their therapeutic strategy in phase I and phase II clinical trials
A Kp, K Kaliaperumal, D Sekar - Epigenomics, 2024 - Taylor & Francis
miRNAs play a crucial therapeutic role in diseases such as cancer, diabetes and viral
infections, with around 1900 identified in the human genome. Some have progressed to …
infections, with around 1900 identified in the human genome. Some have progressed to …
Non-invasive discrimination of adenocarcinoma and squamous cell carcinoma based on differential expression of miR-944 and miR-326 in sputum samples of lung …
Lung cancer (LC) is the leading cause of cancer death globally, with late-stage detection
contributing to poor prognosis and high mortality. Despite efforts to improve therapies, long …
contributing to poor prognosis and high mortality. Despite efforts to improve therapies, long …
Non-coding RNAs and exosomal non-coding RNAs in lung cancer: insights into their functions
X Lv, L Yang, Y Xie, MR Momeni - Frontiers in Cell and …, 2024 - frontiersin.org
Lung cancer is the second most common form of cancer worldwide Research points to the
pivotal role of non-coding RNAs (ncRNAs) in controlling and managing the pathology by …
pivotal role of non-coding RNAs (ncRNAs) in controlling and managing the pathology by …
Diagnostic value of miR-200 family in non-small cell lung cancer: a meta-analysis
Z Ling, L Yang - Biomarkers in Medicine, 2024 - Taylor & Francis
Aim: To investigate the diagnostic potential of the miR-200 family for early detection in non-
small cell lung cancer (NSCLC). Materials & methods: A systematic search was conducted of …
small cell lung cancer (NSCLC). Materials & methods: A systematic search was conducted of …
Lung Lesions: Differential Diagnoses Beyond Cancer.
P Jurczak, A Romaszko-Wojtowicz… - American Journal of …, 2024 - search.ebscohost.com
Abstract Objective: Unusual clinical course Background: Lung cancer is the most common
malignant neoplasm diagnosed worldwide. Early diagnosis and treatment are of great …
malignant neoplasm diagnosed worldwide. Early diagnosis and treatment are of great …